Harvard Bioscience (HBIO) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. ANT
6. META
7. INTC
8. JBLU
9. AAPL
10. NVDA

Go back to Harvard Bioscience (HBIO) Tops Q2 EPS by 1c

Harvard Bioscience Q2 2015 Revenues Increase 7% Year-over-Year, 12% in Constant Currency, to $28.8 Million

July 30, 2015 6:30 AM EDT

-Conference Call To Be Held at 8:30 AM ET Today-

HOLLISTON, Mass., July 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported financial highlights for the three and six months ended June 30, 2015.

Revenues for the second quarter increased to $28.8 million, and non-GAAP earnings per diluted share were $0.05.

Jeffrey A. Duchemin, President and Chief Executive Officer of Harvard Bioscience, stated, "We are pleased to report a strong second quarter which highlights our... More